Product Information
BISOPROLOL FUMARATE 2.5 MG TAB is a generic product labeled by TruPharma LLC, priced at $2.5200 per EA under NDC 52817026830. Its NADAC has been published 50 times since Oct 22, 2025.
FDA first approved this application on Nov 16, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Bisoprolol Fumarate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2.5 mg/1
Manufacturer
TruPharma LLCNDC
52817026830
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BISOPROLOL FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA075643FDA Approved
11/16/2000
TE Code
AB
On Market Since
3/7/2025
Pharmacological Classes
Price Statistics
The NADAC for BISOPROLOL FUMARATE 2.5 MG TAB has been published 50 times since Oct 22, 2025, and over the history we have for it it has declined 2.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.5200 per EA |
|---|---|
| All-time high | $2.6333 (Apr 15, 2026) |
| All-time low | $2.5200 (Sep 23, 2026) |
| 52-week high | $2.6333 |
| 52-week low | $2.5200 |
| Median price | $2.6114 |
| Average price | $2.6047 |
| Largest weekly change | -3.3% (Sep 23, 2026) |
| Weeks tracked | 50 |
| Tracking since | Oct 22, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Bisoprolol Fumarate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
TruPharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Bisoprolol Fumarate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BISOPROLOL FUMARATE 2.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for BISOPROLOL FUMARATE 2.5 MG TAB, manufactured by TruPharma LLC, is $2.5200 per EA (NDC 52817026830), effective Sep 30, 2026.
How has the price of BISOPROLOL FUMARATE 2.5 MG TAB changed over time?
Over the history we have for it, the NADAC for BISOPROLOL FUMARATE 2.5 MG TAB has declined 2.3%. It has been tracked across 50 weekly CMS publications since Oct 22, 2025.
What are the highest and lowest recorded NADAC prices for BISOPROLOL FUMARATE 2.5 MG TAB?
Since Oct 22, 2025, the NADAC for BISOPROLOL FUMARATE 2.5 MG TAB has ranged from a low of $2.5200 (Sep 23, 2026) to a high of $2.6333 (Apr 15, 2026), with a median of $2.6114 per EA.
Are there cheaper alternatives to BISOPROLOL FUMARATE 2.5 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of BISOPROLOL FUMARATE 2.5 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BISOPROLOL FUMARATE 2.5 MG TAB?
BISOPROLOL FUMARATE 2.5 MG TAB (NDC 52817026830) is labeled by TruPharma LLC, and CMS classifies it as a generic product.